Yan Qu

Yan Qu is a scientist in Translational Oncology at Genentech, where she supports pipeline projects from early discovery through clinical stages. With 11 years of industry experience in cancer immunology and cell death mechanisms, she specializes in evaluating targets using preclinical models, conducting efficacy and pharmacodynamic studies, and bridging the translation gap between preclinical findings and clinical outcomes. Yan collaborates closely with discovery teams, clinicians, and biomarker specialists to ensure seamless translation of therapeutic hypotheses from bench to bedside, with expertise in immune cell interactions within the tumor microenvironment.